elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33495209-6C4AAC49-AEAE-47F4-9E84-70E5EBA7016D
Q33495209-6C4AAC49-AEAE-47F4-9E84-70E5EBA7016D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33495209-6C4AAC49-AEAE-47F4-9E84-70E5EBA7016D
Phase II clinical trials with rhizoxin in breast cancer and melanoma. The EORTC Early Clinical Trials Group.
P2860
Q33495209-6C4AAC49-AEAE-47F4-9E84-70E5EBA7016D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33495209-6C4AAC49-AEAE-47F4-9E84-70E5EBA7016D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
04cc46bbcc08c3d230d9a49ef00f55fa3476c6da
P2860
Preclinical antitumour activity and animal toxicology studies of rhizoxin, a novel tubulin-interacting agent.